The protein products of the tumor suppressor genes tuberous sclerosis complex 1 and 2 form a protein complex, TSC1-TSC2, that inhibits growth. Several new studies suggest that TSC1-TSC2 does this by inhibiting TOR and S6 kinase, and that PI 3-kinase-Akt signaling relieves this inhibition.
sensitive to PI 3-kinase-specific inhibitors [15] . But the precise mechanism by which PI 3-kinase-Akt signaling influences S6 kinase activation has been somewhat controversial. Once activated, S6 kinase phosphorylates ribosomal protein S6, thereby promoting translation of a specific class of mRNAs which themselves largely encode ribosomal proteins and other proteins involved in translation.
Phosphorylation of S6 kinase on threonine 389 is also sensitive to the TOR inhibitor, rapamycin [15] ; as TOR is a serine/threonine kinase, this phosphorylation event might be direct. Significantly, TOR activity is promoted by the presence of amino acids and high ATP concentrations, suggesting that TOR might be a nutrient and metabolism sensor [16] . TOR is also thought to phosphorylate 4E-BP1, an inhibitor of the translation initiation factor eIF4E. In this case, phosphorylation inhibits 4E-BP1 function, thereby increasing eIF4E-mediated, cap-dependent translation. The up-regulation of protein translation thus seems to be an important target of both PI 3-kinase-Akt and nutrient-TOR growth signaling.
A role for TSC1-TSC2 in growth control was first suggested by the identification of TSC1 and TSC2 as human tumor suppressor genes (reviewed in [17] ). Loss of heterozygosity at either locus is associated with tuberous sclerosis, a relatively common disease involving the widespread development of benign growths, called hamartomas, some of which contain big cells. Genetic analyses in Drosophila confirmed the importance of TSC1-TSC2 in growth inhibition: mutation of either dTsc1 or dTsc2 enhances growth and increases cell size, whereas co-expression of dTsc1 and dTsc2 inhibits growth and reduces cell size [3] [4] [5] [6] . However, the structures of TSC1 and TSC2 provided few clues as to how the TSC1-TSC2 complex might function at the molecular level. TSC1 has a coiled-coil region and a potential transmembrane domain, while TSC2 has a putative GTPase-activating protein (GAP) domain and a leucine zipper-like sequence [17] .
Earlier research in Drosophila suggested that dS6 kinase might be an inhibitory target of dTsc1-dTsc2 in growth control [4] [5] [6] . Five of the new papers [8] [9] [10] [11] [12] have confirmed this idea using an array of biochemical and molecular assays. For example, decreasing TSC2 expression by RNA interference (RNAi) increases S6 kinase phosphorylation (on the critical threonine 389 residue), whereas overproduction of TSC1-TSC2 is sufficient to inhibit S6 kinase phosphorylation and activation [8, 10] . Moreover, mammalian cells harbouring disease-associated mutations in either TSC1 or TSC2 have constitutively high phosphorylation of both S6 kinase and its substrate S6 [9, 11] .
As TOR is a well-established activator of S6 kinase, some labs went on to test whether TSC1-TSC2 might inhibit S6 kinase indirectly via effects on TOR [8, 10] . Indeed, Inoki et al. [10] found that the ability of TOR to stimulate S6 kinase phosphorylation is compromised when TSC1-TSC2 is overproduced. Taking the converse approach, Gao et al. [8] showed that the increase in dS6 kinase phosphorylation normally observed upon reducing dTsc1-dTsc2 expression is inhibited by attenuating dTOR activity. Significantly, several genetic interactions in Drosophila also place dTOR downstream of dTsc1-dTsc2 [8] . Taken together, these observations strongly suggest that TSC1-TSC2 acts upstream of TOR to inhibit both its kinase activity and its ability to promote growth in vivo. Although it is unclear how TSC1-TSC2 inhibits TOR, direct association and/or phosphorylation may be important, as dTsc2 and dTOR co-immunoprecipitate [8] and phosphorylation of mammalian TOR is sensitive to TSC1-TSC2 levels [10] .
Consistent with the view that TOR acts as a nutrient sensor, S6 kinase and 4E-BP1 phosphorylation normally depends on the nutritional status of the cell. Interestingly, the ability of nutrient stimulation to increase S6 kinase and 4E-BP1 phosphorylation is inhibited by overproduction of TSC1-TSC2 [10] . Conversely, the rapid and sustained decrease in S6 kinase phosphorylation caused by amino acid deprivation is overcome by reducing TSC1-TSC2 levels [8] . These observations suggest that TSC1-TSC2 inhibits the ability of TOR to respond to changes in amino acid/nutrient levels. Alternatively, TSC1-TSC2, rather than TOR, might be the 'primary' nutrient sensor of the cell.
Although [7, 12] . Sequence analysis of human TSC2 identified six potential Akt phosphorylation sites, two of which are conserved in Drosophila dTsc2 [12, 14] . Consistent with these two sites being important, Akt-mediated phosphorylation of TSC2 S939A/T1462A , in which both these residues are altered to non-phosphorylatable alanines, is substantially reduced compared to wild-type [12, 14] . Notably, Akt was found neither to bind nor phosphorylate TSC1 [7, 10] , and the role of TSC1 in the TSC1-TSC2 complex remains unclear.
As would be predicted from genetic data [4-6], Aktmediated phosphorylation of TSC2 inhibits TSC1-TSC2 function. This was shown in several ways. For example, TSC2 S939A/T1462A is more effective than wild-type TSC2 at inhibiting S6 kinase and 4E-BP1 phosphorylation [10, 12] . Potter et al. [14] report equivalent results from experiments using Drosophila wing and eye growth as a read-out. They found that overproduction of nonphosphorylatable dTsc2 -analogous to mammalian TSC2 S939A/T1462A -inhibited growth to a greater extent than the wild-type protein (co-produced with dTsc1). Strikingly, the production of this 'dAkt-resistant' dTsc2 Dispatch R786 claim? While their evidence is persuasive, other data appear to argue against this conclusion. For instance, the increased cell size produced by deleting either dTsc1 or dPTEN is enhanced when both are deleted simultaneously, suggesting that dPI 3-kinase-dAkt signaling can promote growth independently of dTsc1-dTsc2 [4] . Finally, the global importance of TSC1-TSC2-mediated signaling to growth regulation in different in vivo situations remains to be seen. So TSC1-TSC2 has finally taken its place at the center of the growth regulatory network, connecting the nutrient-TOR and PI 3-kinase-Akt growth pathways. It is unlikely to rest in peace. No doubt research is already underway to further characterize the role and regulation of TSC1-TSC2 both during normal growth and in disease.
Figure 1. Generic PI 3-kinase-Akt and nutrient-TOR signaling pathways. (A) In the absence of extracellular growth signals ('OFF'), translation rates are low because TSC1-TSC2 inhibits TOR and 4E-BP1 inhibits eIF4E. (B) In the presence of growth factors ('ON'), PI 3-kinase-Akt signaling is activated. Phosphorylation of TSC2 by Akt promotes its binding to 14-3-3 proteins, somehow inactivating the TSC1-TSC2 complex. This derepresses TOR, leading to phosphorylation of 4E-BP1 and S6 kinase and thus increased translation. TOR activity is also promoted by nutritional inputs, though how is not clear. (See text and [1,2] for details.) Note that this is an oversimplified model and several components have additional upstream inputs and downstream

